Search results
Results from the WOW.Com Content Network
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.
Rs. 21.05 billion (US$73 million) [ 1] (2022) Number of employees. 1,768 [ 1] (2022) Parent. GSK. Website. www .pk .gsk .com. GlaxoSmithKline (GSK) Pakistan is a Pakistani pharmaceutical company which is a subsidiary of British company GSK. [ 2] It is the largest pharmaceutical company in Pakistan.
Rotarix (human rotavirus vaccine, live attenuated) Shingrix (for Zoster Vaccine Recombinant, Adjuvanted) Synflorix (pneumococcal polysaccharide conjugate vaccine (adsorbed)) Twinrix (for combined hepatitis A (inactivated virus) and hepatitis B vaccine (genetically derived surface antigen)) Typherix (typhoid vaccine (purified polysaccharide ...
In the past 52 weeks, GlaxoSmithKline PLC share prices are bracketed by a low of $33.26 and a hi. GlaxoSmithKline PLC (NYSE: GSK) traded at a new 52-week high today of $42.68. This new high was ...
GlaxoSmithKline up on buy, Red Hat shares climbing on earnings, Overstock down on offering.GlaxoSmithKline, Red Hat and Overstock are today's charts
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. [4][5] The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology ...
For premium support please call: 800-290-4726 more ways to reach us
The pharmaceutical industry in Pakistan was estimated to be worth Rs. 748 billion (US$2.6 billion) in 2023, representing about 1% of the country's GDP. [1] The industry is largely import-dependent, with more than 90% of raw material being imported and only 12% of APIs locally produced. [1] Pakistani pharmaceutical companies are engaged in ...